An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study) - supplementary material
收藏数据链接：
官方服务：
资源简介：
Supplementary Table 1. Factors associated with response rateSupplementary Table 2. Factors associated with progression-free survivalSupplementary Table 3. Factors associated with treatment-emergent adverse events (safety analysis set)
提供机构：
Taylor & Francis创建时间：
2024-02-29
